GO:0010388 | cullin deneddylation | 6.34e-07 | 6.19e-03 | 7.315 | 3 | 4 | 8 |
GO:0008180 | COP9 signalosome | 2.24e-05 | 2.18e-01 | 5.730 | 3 | 6 | 24 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 1.11e-04 | 1.00e+00 | 6.922 | 2 | 2 | 7 |
GO:0005736 | DNA-directed RNA polymerase I complex | 2.36e-04 | 1.00e+00 | 6.408 | 2 | 4 | 10 |
GO:0001054 | RNA polymerase I activity | 2.36e-04 | 1.00e+00 | 6.408 | 2 | 4 | 10 |
GO:0030331 | estrogen receptor binding | 1.19e-03 | 1.00e+00 | 5.270 | 2 | 2 | 22 |
GO:0018160 | peptidyl-pyrromethane cofactor linkage | 2.36e-03 | 1.00e+00 | 8.730 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 2.36e-03 | 1.00e+00 | 8.730 | 1 | 1 | 1 |
GO:0004418 | hydroxymethylbilane synthase activity | 2.36e-03 | 1.00e+00 | 8.730 | 1 | 1 | 1 |
GO:0000775 | chromosome, centromeric region | 4.12e-03 | 1.00e+00 | 4.372 | 2 | 6 | 41 |
GO:0051716 | cellular response to stimulus | 4.71e-03 | 1.00e+00 | 7.730 | 1 | 1 | 2 |
GO:0009368 | endopeptidase Clp complex | 4.71e-03 | 1.00e+00 | 7.730 | 1 | 1 | 2 |
GO:0036123 | histone H3-K9 dimethylation | 7.05e-03 | 1.00e+00 | 7.145 | 1 | 1 | 3 |
GO:0000778 | condensed nuclear chromosome kinetochore | 7.05e-03 | 1.00e+00 | 7.145 | 1 | 2 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 7.05e-03 | 1.00e+00 | 7.145 | 1 | 1 | 3 |
GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly | 7.05e-03 | 1.00e+00 | 7.145 | 1 | 1 | 3 |
GO:0042582 | azurophil granule | 9.39e-03 | 1.00e+00 | 6.730 | 1 | 1 | 4 |
GO:0032057 | negative regulation of translational initiation in response to stress | 9.39e-03 | 1.00e+00 | 6.730 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 9.39e-03 | 1.00e+00 | 6.730 | 1 | 2 | 4 |
GO:0006333 | chromatin assembly or disassembly | 9.39e-03 | 1.00e+00 | 6.730 | 1 | 1 | 4 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 9.39e-03 | 1.00e+00 | 6.730 | 1 | 2 | 4 |
GO:0016779 | nucleotidyltransferase activity | 9.39e-03 | 1.00e+00 | 6.730 | 1 | 1 | 4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 9.39e-03 | 1.00e+00 | 6.730 | 1 | 1 | 4 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.17e-02 | 1.00e+00 | 6.408 | 1 | 2 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.17e-02 | 1.00e+00 | 6.408 | 1 | 1 | 5 |
GO:0060744 | mammary gland branching involved in thelarche | 1.17e-02 | 1.00e+00 | 6.408 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.17e-02 | 1.00e+00 | 6.408 | 1 | 1 | 5 |
GO:0001649 | osteoblast differentiation | 1.29e-02 | 1.00e+00 | 3.520 | 2 | 5 | 74 |
GO:0050847 | progesterone receptor signaling pathway | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 2 | 6 |
GO:0001055 | RNA polymerase II activity | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 3 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 2 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 2 | 6 |
GO:0006903 | vesicle targeting | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 1 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.64e-02 | 1.00e+00 | 5.922 | 1 | 4 | 7 |
GO:0007140 | male meiosis | 1.64e-02 | 1.00e+00 | 5.922 | 1 | 1 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 1.64e-02 | 1.00e+00 | 5.922 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.64e-02 | 1.00e+00 | 5.922 | 1 | 4 | 7 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 1.64e-02 | 1.00e+00 | 5.922 | 1 | 2 | 7 |
GO:0051382 | kinetochore assembly | 1.64e-02 | 1.00e+00 | 5.922 | 1 | 2 | 7 |
GO:0042581 | specific granule | 1.64e-02 | 1.00e+00 | 5.922 | 1 | 1 | 7 |
GO:0004535 | poly(A)-specific ribonuclease activity | 1.87e-02 | 1.00e+00 | 5.730 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.87e-02 | 1.00e+00 | 5.730 | 1 | 1 | 8 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.87e-02 | 1.00e+00 | 5.730 | 1 | 1 | 8 |
GO:0071354 | cellular response to interleukin-6 | 2.10e-02 | 1.00e+00 | 5.560 | 1 | 1 | 9 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 2.10e-02 | 1.00e+00 | 5.560 | 1 | 2 | 9 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.10e-02 | 1.00e+00 | 5.560 | 1 | 1 | 9 |
GO:0005515 | protein binding | 2.21e-02 | 1.00e+00 | 0.627 | 15 | 198 | 4124 |
GO:0005095 | GTPase inhibitor activity | 2.33e-02 | 1.00e+00 | 5.408 | 1 | 1 | 10 |
GO:0042974 | retinoic acid receptor binding | 2.33e-02 | 1.00e+00 | 5.408 | 1 | 1 | 10 |
GO:0009416 | response to light stimulus | 2.33e-02 | 1.00e+00 | 5.408 | 1 | 1 | 10 |
GO:0030014 | CCR4-NOT complex | 2.33e-02 | 1.00e+00 | 5.408 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.56e-02 | 1.00e+00 | 5.270 | 1 | 4 | 11 |
GO:2000036 | regulation of stem cell maintenance | 2.56e-02 | 1.00e+00 | 5.270 | 1 | 1 | 11 |
GO:0006783 | heme biosynthetic process | 2.56e-02 | 1.00e+00 | 5.270 | 1 | 2 | 11 |
GO:0000132 | establishment of mitotic spindle orientation | 2.79e-02 | 1.00e+00 | 5.145 | 1 | 2 | 12 |
GO:0004527 | exonuclease activity | 2.79e-02 | 1.00e+00 | 5.145 | 1 | 4 | 12 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 2.79e-02 | 1.00e+00 | 5.145 | 1 | 1 | 12 |
GO:0006778 | porphyrin-containing compound metabolic process | 2.79e-02 | 1.00e+00 | 5.145 | 1 | 2 | 12 |
GO:0061025 | membrane fusion | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 1 | 13 |
GO:0005680 | anaphase-promoting complex | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 2 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 3 | 13 |
GO:0060749 | mammary gland alveolus development | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 3.25e-02 | 1.00e+00 | 4.922 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 3.25e-02 | 1.00e+00 | 4.922 | 1 | 3 | 14 |
GO:0016575 | histone deacetylation | 3.25e-02 | 1.00e+00 | 4.922 | 1 | 2 | 14 |
GO:0010467 | gene expression | 3.44e-02 | 1.00e+00 | 1.666 | 4 | 49 | 535 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 1 | 15 |
GO:0014003 | oligodendrocyte development | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 4 | 15 |
GO:0000398 | mRNA splicing, via spliceosome | 3.60e-02 | 1.00e+00 | 2.730 | 2 | 15 | 128 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.71e-02 | 1.00e+00 | 2.006 | 3 | 17 | 317 |
GO:0001829 | trophectodermal cell differentiation | 3.93e-02 | 1.00e+00 | 4.642 | 1 | 2 | 17 |
GO:0003899 | DNA-directed RNA polymerase activity | 4.16e-02 | 1.00e+00 | 4.560 | 1 | 3 | 18 |
GO:0031047 | gene silencing by RNA | 4.16e-02 | 1.00e+00 | 4.560 | 1 | 2 | 18 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 4.39e-02 | 1.00e+00 | 4.482 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.39e-02 | 1.00e+00 | 4.482 | 1 | 1 | 19 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 4.39e-02 | 1.00e+00 | 4.482 | 1 | 1 | 19 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 4.39e-02 | 1.00e+00 | 4.482 | 1 | 1 | 19 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.46e-02 | 1.00e+00 | 1.901 | 3 | 23 | 341 |
GO:0034080 | CENP-A containing nucleosome assembly | 4.61e-02 | 1.00e+00 | 4.408 | 1 | 2 | 20 |
GO:0070979 | protein K11-linked ubiquitination | 4.61e-02 | 1.00e+00 | 4.408 | 1 | 3 | 20 |
GO:0005720 | nuclear heterochromatin | 4.61e-02 | 1.00e+00 | 4.408 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 4.61e-02 | 1.00e+00 | 4.408 | 1 | 2 | 20 |
GO:0005634 | nucleus | 4.69e-02 | 1.00e+00 | 0.650 | 12 | 158 | 3246 |
GO:0006363 | termination of RNA polymerase I transcription | 4.84e-02 | 1.00e+00 | 4.338 | 1 | 3 | 21 |
GO:0005654 | nucleoplasm | 4.96e-02 | 1.00e+00 | 1.277 | 5 | 68 | 876 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.06e-02 | 1.00e+00 | 4.270 | 1 | 2 | 22 |
GO:0051084 | 'de novo' posttranslational protein folding | 5.06e-02 | 1.00e+00 | 4.270 | 1 | 4 | 22 |
GO:0006370 | 7-methylguanosine mRNA capping | 5.51e-02 | 1.00e+00 | 4.145 | 1 | 5 | 24 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 5.51e-02 | 1.00e+00 | 4.145 | 1 | 4 | 24 |
GO:0008380 | RNA splicing | 5.69e-02 | 1.00e+00 | 2.364 | 2 | 21 | 165 |
GO:0016592 | mediator complex | 5.73e-02 | 1.00e+00 | 4.086 | 1 | 6 | 25 |
GO:0007094 | mitotic spindle assembly checkpoint | 5.73e-02 | 1.00e+00 | 4.086 | 1 | 4 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 5.73e-02 | 1.00e+00 | 4.086 | 1 | 3 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 6.18e-02 | 1.00e+00 | 3.975 | 1 | 4 | 27 |
GO:0008233 | peptidase activity | 6.40e-02 | 1.00e+00 | 3.922 | 1 | 2 | 28 |
GO:0005739 | mitochondrion | 6.54e-02 | 1.00e+00 | 1.366 | 4 | 32 | 659 |
GO:0006383 | transcription from RNA polymerase III promoter | 6.62e-02 | 1.00e+00 | 3.872 | 1 | 6 | 29 |
GO:0005778 | peroxisomal membrane | 6.62e-02 | 1.00e+00 | 3.872 | 1 | 3 | 29 |
GO:0009408 | response to heat | 7.06e-02 | 1.00e+00 | 3.776 | 1 | 1 | 31 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 7.06e-02 | 1.00e+00 | 3.776 | 1 | 6 | 31 |
GO:0006892 | post-Golgi vesicle-mediated transport | 7.28e-02 | 1.00e+00 | 3.730 | 1 | 1 | 32 |
GO:0000786 | nucleosome | 7.72e-02 | 1.00e+00 | 3.642 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 7.72e-02 | 1.00e+00 | 3.642 | 1 | 1 | 34 |
GO:0016032 | viral process | 7.74e-02 | 1.00e+00 | 1.573 | 3 | 30 | 428 |
GO:0005743 | mitochondrial inner membrane | 7.77e-02 | 1.00e+00 | 2.108 | 2 | 9 | 197 |
GO:0050434 | positive regulation of viral transcription | 7.94e-02 | 1.00e+00 | 3.601 | 1 | 5 | 35 |
GO:0044297 | cell body | 7.94e-02 | 1.00e+00 | 3.601 | 1 | 5 | 35 |
GO:0043434 | response to peptide hormone | 8.15e-02 | 1.00e+00 | 3.560 | 1 | 1 | 36 |
GO:0003743 | translation initiation factor activity | 8.37e-02 | 1.00e+00 | 3.520 | 1 | 8 | 37 |
GO:0048511 | rhythmic process | 8.59e-02 | 1.00e+00 | 3.482 | 1 | 5 | 38 |
GO:0006417 | regulation of translation | 8.80e-02 | 1.00e+00 | 3.444 | 1 | 2 | 39 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 8.97e-02 | 1.00e+00 | 1.482 | 3 | 29 | 456 |
GO:0006396 | RNA processing | 9.02e-02 | 1.00e+00 | 3.408 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 9.02e-02 | 1.00e+00 | 3.408 | 1 | 6 | 40 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 9.02e-02 | 1.00e+00 | 3.408 | 1 | 4 | 40 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 2 | 43 |
GO:0000932 | cytoplasmic mRNA processing body | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 3 | 43 |
GO:0006887 | exocytosis | 9.88e-02 | 1.00e+00 | 3.270 | 1 | 1 | 44 |
GO:0009749 | response to glucose | 1.01e-01 | 1.00e+00 | 3.238 | 1 | 1 | 45 |
GO:0019903 | protein phosphatase binding | 1.05e-01 | 1.00e+00 | 3.175 | 1 | 2 | 47 |
GO:0032481 | positive regulation of type I interferon production | 1.07e-01 | 1.00e+00 | 3.145 | 1 | 3 | 48 |
GO:0005829 | cytosol | 1.12e-01 | 1.00e+00 | 0.734 | 7 | 88 | 1787 |
GO:0006334 | nucleosome assembly | 1.14e-01 | 1.00e+00 | 3.057 | 1 | 4 | 51 |
GO:0044822 | poly(A) RNA binding | 1.14e-01 | 1.00e+00 | 1.088 | 4 | 45 | 799 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.16e-01 | 1.00e+00 | 3.029 | 1 | 3 | 52 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.16e-01 | 1.00e+00 | 3.029 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 1.18e-01 | 1.00e+00 | 3.002 | 1 | 6 | 53 |
GO:0003682 | chromatin binding | 1.18e-01 | 1.00e+00 | 1.753 | 2 | 15 | 252 |
GO:0006338 | chromatin remodeling | 1.22e-01 | 1.00e+00 | 2.948 | 1 | 7 | 55 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.24e-01 | 1.00e+00 | 2.922 | 1 | 5 | 56 |
GO:0003697 | single-stranded DNA binding | 1.26e-01 | 1.00e+00 | 2.897 | 1 | 4 | 57 |
GO:0042826 | histone deacetylase binding | 1.28e-01 | 1.00e+00 | 2.872 | 1 | 5 | 58 |
GO:0000785 | chromatin | 1.30e-01 | 1.00e+00 | 2.847 | 1 | 6 | 59 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.32e-01 | 1.00e+00 | 2.823 | 1 | 5 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 1.34e-01 | 1.00e+00 | 2.799 | 1 | 5 | 61 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.43e-01 | 1.00e+00 | 2.707 | 1 | 7 | 65 |
GO:0003676 | nucleic acid binding | 1.45e-01 | 1.00e+00 | 2.685 | 1 | 4 | 66 |
GO:0005730 | nucleolus | 1.50e-01 | 1.00e+00 | 0.803 | 5 | 74 | 1217 |
GO:0030308 | negative regulation of cell growth | 1.53e-01 | 1.00e+00 | 2.601 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.53e-01 | 1.00e+00 | 2.601 | 1 | 5 | 70 |
GO:0016363 | nuclear matrix | 1.59e-01 | 1.00e+00 | 2.540 | 1 | 10 | 73 |
GO:0071456 | cellular response to hypoxia | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 2 | 76 |
GO:0000278 | mitotic cell cycle | 1.68e-01 | 1.00e+00 | 1.435 | 2 | 28 | 314 |
GO:0004252 | serine-type endopeptidase activity | 1.69e-01 | 1.00e+00 | 2.444 | 1 | 1 | 78 |
GO:0030529 | ribonucleoprotein complex | 1.76e-01 | 1.00e+00 | 2.372 | 1 | 5 | 82 |
GO:0045202 | synapse | 1.78e-01 | 1.00e+00 | 2.355 | 1 | 3 | 83 |
GO:0051260 | protein homooligomerization | 1.86e-01 | 1.00e+00 | 2.287 | 1 | 2 | 87 |
GO:0061024 | membrane organization | 1.90e-01 | 1.00e+00 | 2.254 | 1 | 2 | 89 |
GO:0044267 | cellular protein metabolic process | 2.00e-01 | 1.00e+00 | 1.270 | 2 | 14 | 352 |
GO:0042802 | identical protein binding | 2.02e-01 | 1.00e+00 | 1.262 | 2 | 15 | 354 |
GO:0006457 | protein folding | 2.05e-01 | 1.00e+00 | 2.130 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 2.09e-01 | 1.00e+00 | 2.100 | 1 | 6 | 99 |
GO:0010628 | positive regulation of gene expression | 2.22e-01 | 1.00e+00 | 2.002 | 1 | 2 | 106 |
GO:0043547 | positive regulation of GTPase activity | 2.33e-01 | 1.00e+00 | 1.922 | 1 | 2 | 112 |
GO:0042981 | regulation of apoptotic process | 2.33e-01 | 1.00e+00 | 1.922 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 2.35e-01 | 1.00e+00 | 1.910 | 1 | 6 | 113 |
GO:0007049 | cell cycle | 2.39e-01 | 1.00e+00 | 1.884 | 1 | 8 | 115 |
GO:0005759 | mitochondrial matrix | 2.81e-01 | 1.00e+00 | 1.611 | 1 | 7 | 139 |
GO:0044212 | transcription regulatory region DNA binding | 2.88e-01 | 1.00e+00 | 1.570 | 1 | 13 | 143 |
GO:0001701 | in utero embryonic development | 3.07e-01 | 1.00e+00 | 1.463 | 1 | 7 | 154 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 3.18e-01 | 1.00e+00 | 1.399 | 1 | 18 | 161 |
GO:0005874 | microtubule | 3.21e-01 | 1.00e+00 | 1.381 | 1 | 10 | 163 |
GO:0007067 | mitotic nuclear division | 3.25e-01 | 1.00e+00 | 1.364 | 1 | 9 | 165 |
GO:0016071 | mRNA metabolic process | 3.33e-01 | 1.00e+00 | 1.320 | 1 | 10 | 170 |
GO:0070062 | extracellular vesicular exosome | 3.42e-01 | 1.00e+00 | 0.371 | 5 | 51 | 1641 |
GO:0006412 | translation | 3.45e-01 | 1.00e+00 | 1.254 | 1 | 12 | 178 |
GO:0004842 | ubiquitin-protein transferase activity | 3.47e-01 | 1.00e+00 | 1.246 | 1 | 17 | 179 |
GO:0016567 | protein ubiquitination | 3.61e-01 | 1.00e+00 | 1.175 | 1 | 14 | 188 |
GO:0016070 | RNA metabolic process | 3.61e-01 | 1.00e+00 | 1.175 | 1 | 10 | 188 |
GO:0015031 | protein transport | 3.84e-01 | 1.00e+00 | 1.065 | 1 | 10 | 203 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 3.84e-01 | 1.00e+00 | 1.065 | 1 | 14 | 203 |
GO:0006281 | DNA repair | 3.84e-01 | 1.00e+00 | 1.065 | 1 | 24 | 203 |
GO:0030154 | cell differentiation | 3.85e-01 | 1.00e+00 | 1.057 | 1 | 5 | 204 |
GO:0003677 | DNA binding | 3.89e-01 | 1.00e+00 | 0.428 | 3 | 52 | 947 |
GO:0043234 | protein complex | 3.94e-01 | 1.00e+00 | 1.016 | 1 | 13 | 210 |
GO:0019899 | enzyme binding | 3.94e-01 | 1.00e+00 | 1.016 | 1 | 7 | 210 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 4.02e-01 | 1.00e+00 | 0.545 | 2 | 22 | 582 |
GO:0005737 | cytoplasm | 4.30e-01 | 1.00e+00 | 0.175 | 7 | 127 | 2633 |
GO:0007165 | signal transduction | 4.32e-01 | 1.00e+00 | 0.458 | 2 | 24 | 618 |
GO:0003723 | RNA binding | 4.46e-01 | 1.00e+00 | 0.781 | 1 | 22 | 247 |
GO:0006508 | proteolysis | 4.68e-01 | 1.00e+00 | 0.685 | 1 | 11 | 264 |
GO:0046982 | protein heterodimerization activity | 4.69e-01 | 1.00e+00 | 0.680 | 1 | 11 | 265 |
GO:0006351 | transcription, DNA-templated | 4.73e-01 | 1.00e+00 | 0.243 | 3 | 47 | 1076 |
GO:0008285 | negative regulation of cell proliferation | 4.85e-01 | 1.00e+00 | 0.616 | 1 | 11 | 277 |
GO:0005925 | focal adhesion | 4.91e-01 | 1.00e+00 | 0.590 | 1 | 14 | 282 |
GO:0009986 | cell surface | 5.02e-01 | 1.00e+00 | 0.545 | 1 | 5 | 291 |
GO:0006355 | regulation of transcription, DNA-templated | 5.10e-01 | 1.00e+00 | 0.248 | 2 | 31 | 715 |
GO:0008270 | zinc ion binding | 5.19e-01 | 1.00e+00 | 0.224 | 2 | 39 | 727 |
GO:0016020 | membrane | 5.54e-01 | 1.00e+00 | 0.078 | 3 | 56 | 1207 |
GO:0045893 | positive regulation of transcription, DNA-templated | 5.96e-01 | 1.00e+00 | 0.171 | 1 | 21 | 377 |
GO:0005524 | ATP binding | 6.34e-01 | 1.00e+00 | -0.071 | 2 | 37 | 892 |
GO:0045087 | innate immune response | 6.64e-01 | 1.00e+00 | -0.090 | 1 | 12 | 452 |
GO:0005887 | integral component of plasma membrane | 7.53e-01 | 1.00e+00 | -0.438 | 1 | 8 | 575 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.92e-01 | 1.00e+00 | -0.601 | 1 | 29 | 644 |
GO:0005615 | extracellular space | 7.96e-01 | 1.00e+00 | -0.617 | 1 | 15 | 651 |
GO:0044281 | small molecule metabolic process | 8.75e-01 | 1.00e+00 | -0.991 | 1 | 35 | 844 |
GO:0016021 | integral component of membrane | 9.80e-01 | 1.00e+00 | -1.846 | 1 | 19 | 1526 |
GO:0005886 | plasma membrane | 9.90e-01 | 1.00e+00 | -2.071 | 1 | 46 | 1784 |